Article citationsMore>>

Saha, L., Pandhi, P., Gopalan, S., Malhotra, S. and Saha, P.K. (2007) Comparison of Efficacy, Tolerability, and Cost of Iron (III) Hydroxide Polymaltose versus Ferrous Sulfate in the Treatment of Iron-Deficiency Anemia in Pregnant Women. Medscape General Medicine, 9, Article 1.

has been cited by the following article:

• TITLE: Effectiveness, Adherence and Tolerability to Iron (III) Hydroxide Polymaltose in Pregnant Women with Iron Deficiency Anemia: Findings from a Multicenter, Prospective, Single-Arm Study in Angola

  AUTHORS: Mário Bundo

  KEYWORDS: Iron Deficiency Anemia, Pregnancy, Ferric Hydroxide Polymaltose Complex, Hemoglobin, Angola

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.16 No.5, May 12, 2026

  ABSTRACT: Introduction: Iron deficiency anemia (IDA) is the most common hematologic complication during pregnancy, particularly in low- and middle-income countries. This study aimed to evaluate the efficacy and adherence to Iron (III) Hydroxide Polymaltose in improving hemoglobin (Hb) levels in pregnant women with IDA in Angola. Methods: A prospective, interventional, multicenter study was conducted in 3 healthcare centres in Angola. Iron (III) Hydroxide Polymaltose syrup (Hemoforce Gravida®) was used. A total of 200 pregnant women were recruited; however, 11 were lost to follow-up. Hence, a total of 189 pregnant women with Hb Results: After 28 days, a mean hemoglobin increase of 1.45 ± 0.92 g/dL was observed (p Conclusion: Iron (III) Hydroxide Polymaltose syrup is effective and well-tolerated in treating IDA during pregnancy and represents a viable option in resource-limited settings.